Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.
Beijing, San Francisco and Boston, December 8, 2021 – Avistone Pharmaceuticals (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced it has received a strategic investment of more than $200 million led by Vivo Capital with participation from Bain Capital and Primavera Capital (collectively the “Investor...
Boston, MA, October 27, 2021 – Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced it has received a private investment of up to $300 million from Bain Capital Life...
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and CM Life Sciences III, Inc. (NASDAQ: CMLTU), a life science-focused special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. today announced the closing of an oversubscribed $135 million Series C financing, led by Viking Global Investors, to support the clinical development and potential launch plans for lead product candidate AMX0035, for the potential treatment of ALS, and further research and development in other neurodegenerative diseases.The financing...
CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. New investors HealthCor Investments LLC and Innovatus Capital Partners, LLC also joined the round. Existing Imperative Care investors Ally Bridge Group, Bain Capital Life Sciences, Ascension Ventures, Delos Capital, Rock Springs Capital,...
SAN DIEGO, June 9, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the closing of a $45 million financing tranche that brings the total Series D financing to more than $115 million. The financing includes participation by existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures, as well as...
PHILADELPHIA, May 18, 2021 /PRNewswire/ -- Interius BioTherapeutics, a preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery, today announced that it has raised $76 million in an oversubscribed Series A financing. The round was co-led by Cormorant Asset Management and Fairmount Funds, and joined by Bain Capital Life Sciences,...
CAMBRIDGE, Mass., May 11, 2021 /PRNewswire/ -- Nuvalent, Inc., a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the completion of a $135 million Series B financing. The round was led by Bain Capital Life Sciences with participation from sole founding investor, Deerfield Management, and additional new investors...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (Nasdaq: BCTG), a special purpose acquisition company (SPAC) sponsored by Boxer Capital, today announced they have entered into a definitive merger agreement. Upon closing of the transaction, the...
CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced an up to $125 million non-dilutive financing transaction with NovaQuest and Bain Capital to fund the full Phase 3 development program for tavapadon in Parkinson’s disease, also known as the TEMPO...
Find out how the @C2CBoston mission was born in this article. Read about their history here. https://t.co/kCGjXkKW4o
Congratulations to #BainCapitalCredit’s Carolyn Kelly Hastings and the rest of the women named to the… https://t.co/iNq9mZW1ZN
#BainCapitalRealEstate, in partnership with Oliver Street Capital, announced the #acquisition of three infill… https://t.co/4nchUivrOv
Learn how more than 110 @DanaFarber affiliated faculty have been named as 2022 Top Doctors in @BostonMagazine. Re… https://t.co/2HAgolKFoo
Learn about the 2022 @Cycle4Survival events and why it's important to join them for the ride here. https://t.co/I4L26rhopG
Join @RosiesPlace for the Safe and Sound Gala on May 4, 2022. Learn more here. https://t.co/l2fzi9CnkQ
Check out the research behind @YearUp -- read more here. https://t.co/DbImbGqgpt
Building on extensive experience helping #tech companies reach their full potential, #BainCapitalPrivateEquity is l… https://t.co/FdqcE70JjN
Looking for ways to give back to your community? Host a @TheJimmyFund event. Learn how to host here. https://t.co/OOhkxXsIwj
An anonymous @PanMass Challenge couple has pledged that every PMC 2022 rider registration fee will be matched dolla… https://t.co/Hx7mm8cU1k